A new drug looks set to help people with ‘stubborn’ high blood pressure that fails to respond to existing medicines.

If approved, the tablets, called baxdrostat, would be the first new kind of treatment for high blood pressure in 20 years.

In people who still had high blood pressure despite taking two or three medicines, the addition of baxdrostat significantly cut their blood pressure within a month.

The drop was big enough to meaningfully lower their risk of heart attacks and strokes, among the main risks from high blood pressure, said Professor Bryan Williams, chair of medicine at University College London, who led the trial.

“These findings are an important advance in treatment of difficult-to-control blood pressure,” he added.

How low should blood pressure go?

NHS guidelin

See Full Page